Clinical Trial Update: Phase IIa L-serine Trial for eAD [Phase 2]

View source ↗

Summary

A Phase IIa clinical trial of L-serine for Alzheimer's disease was terminated; results were posted on July 3, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• L-serine (L-serine)

Snippet

Sponsor: Aleksandra Stark | Conditions: Alzheimer Disease | Phase 2 | Status: TERMINATED | Results posted: 2024-07-03